Osenvelt Injection
Product Images NDC 72606-038

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Osenvelt (NDC 72606-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Osenvelt 01)

A line graph showing corrected calcium levels over study days for Denosumab 120 mg (N=23) users. The x-axis displays study days from baseline (BL) to day 57, while the y-axes on left and right show calcium levels in mmol/L and mg/dL, respectively. Data points indicate a decline in calcium levels with error bars representing variability.*

FDA Label Image

Principal Display Panel (120 mg/1.7 mL Vial Carton)

Packaging label for Osenvelt (denosumab-bmwo) injection, 120 mg/1.7 mL (70 mg/mL) for subcutaneous use. The label indicates a single-dose vial with no preservative, manufactured by CELLTRION USA, Inc. It includes dosage form, strength, usage instructions, storage conditions, active ingredients in solution, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.